课题基金 / 基金详情

RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT

RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT
钌抗癌药物-转铁蛋白加合物的 RU K-EDGE EXAFS 分析
批准号:
8362258
负责人:
KAREN MCFARLANE HOLMAN
金额:
$0.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-03-01 至 2012-02-29

项目摘要

项目成果

KAREN MCFARLANE HOLMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. We have synthesized and collected Ru K-edge EXAFS data on KP1019 and several biomimetic complexes (KP1019-amino acid adducts). We will measure EXAFS data on the KP1019-transferrin adduct in order to provide the first geometrical insight into the Ru-drug binding site in this system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT
  • 批准号:
    8362379
  • 项目类别:
  • 资助金额:
    $0.14万
  • 财政年份:
    2011
  • 负责人:
    KAREN MCFARLANE HOLMAN
  • 依托单位:
RU K-EDGE EXAFS ANALYSIS OF A RUTHENIUM ANTICANCER DRUG-TRANSFERRIN ADDUCT
  • 批准号:
    8170241
  • 项目类别:
  • 资助金额:
    $0.03万
  • 财政年份:
    2010
  • 负责人:
    KAREN MCFARLANE HOLMAN
  • 依托单位:
海外基金